“Global Genomics market set to grow to $23bn by 2022” says new Visiongain report

01 November 2018
Pharma

Visiongain has launched a new pharma report: Global Genomics Market Report 2018-2028: Sequencing, Microarray, PCR, Nucleic Acid Extraction and Purification, Diagnostic Test, Genetic Test, Newborn Screening, Preimplantation Testing, Prenatal Testing, Carrier Testing, Molecular Test, Chromosomal Test, Biochemical Test, Diagnostic, Drug Discovery, Precision Medicine, Research Centers, Hospitals and Clinics, Pharmaceutical Companies and Others.

Genome-based research is already empowering medical researchers to develop improved diagnostics, more effective therapeutic strategies, evidence-based approaches for demonstrating clinical efficacy, and better decision-making tools for patients and providers. The genomics market has been segmented based on technology, test type, method, application, end-user, and geography.

The lead analyst of the report commented "Genomics market is quite fragmented. Companies are investing in research and development activities and the industry growth is highly positive. There is a strong and established customer base for genomics market which is continually progressing. The products are very much undifferentiated as the technological arena is limited to certain extents and, each application segment is demanding technological advancement.

With increasing demand for diagnostic and precision medicines, market players are introducing product developments to differentiate themselves with the best and cost-effective solutions to the market. There is a presence of many domestic and global level players with intense competition among each other."

Leading companies featured in the report include Agilent Technologies, Inc., Danaher Corporation, Eppendorf AG, BGI Genomics Co. Ltd., Eurofins Scientific, GE Healthcare Life Sciences, Illumina, Inc., Oxford Nanopore Technologies Ltd., Qiagen NV, Roche, Thermo Fisher Scientific, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Biochips Market Report 2020-2030

Conceptually, it is clear for all stakeholders in the health care segment as well in the biotechnological sector the benefits are evident since it will improve the speed and accuracy of diagnostics or analysis.

05 August 2020

Read

Visiongain Publishes Cell and Gene Supply Chain Services and Solutions Market Report 2020-2030

With the threat of growing number of patients due to the COVID-19 infections, the supply chain trends are looking at a shift with no contact and social distancing policies.

03 August 2020

Read

Visiongain Publishes Advanced Wound Care Market Report 2020-2030

Traditional wound care such as gauze and compression therapies are less effective than active wound care products. Active wound dressings create an environment more suitable for healing.

03 August 2020

Read

Visiongain Publishes Pregnancy Care Products Market Report 2020-2030

Advancement in development of organic pregnancy care products that are more safe and effective to improve physical appearance concerns such as stretchmark and sagging breasts and increase in awareness of the benefits of using these products through promotion of these products on social media platforms have increased the demand for pregnancy care products.

30 July 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever